With 116 companies funded in 4.5 years, IndieBio is enabling scientists to build transformative companies in human and planetary health and rejecting conventional thought that funding biotech must be expensive. Alex Kopelyan, Partner and Program Director at IndieBio shared this illuminating presentation at ABLC NEXT in San Francisco that talks about their lab space, engineering biology, evolving modalities and more.
Use your ← → (arrow) keys to browse